Lexicon Pharmaceuticals, Inc. (LXRX)
NASDAQ: LXRX · Real-Time Price · USD
1.650
+0.050 (3.12%)
At close: Oct 15, 2026, 4:00 PM EDT
1.640
-0.010 (-0.61%)
After-hours: Oct 15, 2026, 7:30 PM EDT
Lexicon Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, Lexicon Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of $4.55. The average 1-year stock price forecast is 175.76% higher than the current stock price, while the lowest is $2.00 (+21.21%) and the highest is $8.00 (+384.85%).
Price Target: $4.55 (+175.76%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Lexicon Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $8 | Buy | Initiates | $8 | +384.85% | Sep 28, 2026 |
| Citi | Citi | Buy Maintains $3.1 | Buy | Maintains | $3.1 | +87.88% | Sep 11, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $6 | Buy | Maintains | $6 | +263.64% | Aug 24, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $6 | Buy | Maintains | $6 | +263.64% | Aug 7, 2026 |
Financial Forecast
Revenue This Year
37.17M
from 49.80M
Decreased by -25.37%
Revenue Next Year
16.93M
from 37.17M
Decreased by -54.44%
EPS This Year
-0.17
from -0.14
EPS Next Year
-0.19
from -0.17
EPS and Forward PE are based on non-GAAP adjusted numbers.